Carmell Cosmetics Acquires Elevai Labs, Expands Physician-Dispensed Skin Care Market Reach

Amidst projected surges in the physician-dispensed skin care market, Carmell Cosmetics has acquired Elevai Labs, a manufacturer of physician-dispensed, exosome-based products to deepen Carmell’s advancement: secretomes.
Amidst projected surges in the physician-dispensed skin care market, Carmell Cosmetics has acquired Elevai Labs, a manufacturer of physician-dispensed, exosome-based products to deepen Carmell’s advancement: secretomes.
Jacob Lund at Adobe Stock

Amidst projected surges in the physician-dispensed skin care market, Carmell Cosmetics has acquired Elevai Labs, a manufacturer of physician-dispensed, exosome-based products to deepen Carmell’s advancement: secretomes. According to Straits Research, the physician dispensed market size was valued at $10.7 billion in 2023 and is estimated to reach $23.83 billion by 2032, growing at a CAGR of 8.3%.

Log in to view the full article
More in Companies